Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse.

Schmitt KC, Reith ME.

Ann N Y Acad Sci. 2010 Feb;1187:316-40. doi: 10.1111/j.1749-6632.2009.05148.x. Review.

PMID:
20201860
2.

Rapid regulation of the dopamine transporter: role in stimulant addiction?

Zahniser NR, Sorkin A.

Neuropharmacology. 2004;47 Suppl 1:80-91. Review.

PMID:
15464127
3.

The dopamine transporter: a vigilant border control for psychostimulant action.

Williams JM, Galli A.

Handb Exp Pharmacol. 2006;(175):215-32. Review.

PMID:
16722238
4.

Regulation of the dopamine transporter by phosphorylation.

Foster JD, Cervinski MA, Gorentla BK, Vaughan RA.

Handb Exp Pharmacol. 2006;(175):197-214. Review.

PMID:
16722237
5.

[The dopamine transporter: characterization and physiopathologic implications].

Thibaut F, Vaugeois JM, Petit M.

Encephale. 1995 Nov-Dec;21(6):445-51. Review. French.

PMID:
8674469
6.

The dopamine transporter proteome.

Torres GE.

J Neurochem. 2006 Apr;97 Suppl 1:3-10. Review.

7.

Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.

Kahlig KM, Galli A.

Eur J Pharmacol. 2003 Oct 31;479(1-3):153-8. Review.

PMID:
14612146
9.

Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.

Seger D.

Clin Toxicol (Phila). 2010 Aug;48(7):695-708. doi: 10.3109/15563650.2010.516263. Review.

PMID:
20849328
10.

Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.

Eriksen J, Jørgensen TN, Gether U.

J Neurochem. 2010 Apr;113(1):27-41. doi: 10.1111/j.1471-4159.2010.06599.x. Epub 2010 Jan 18. Review.

11.

Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum.

Loonam TM, Noailles PA, Yu J, Zhu JP, Angulo JA.

Life Sci. 2003 Jun 27;73(6):727-39. Review.

PMID:
12801594
12.

[Behavioral and pharmacological characteristics of mice lacking the dopamine transporter].

Biala G.

Postepy Hig Med Dosw (Online). 2004;58:560-4. Review. Polish.

13.

Neuroadaptations involved in amphetamine and cocaine addiction.

White FJ, Kalivas PW.

Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):141-53. Review. No abstract available.

PMID:
9716936
14.

Trafficking of dopamine transporters in psychostimulant actions.

Zahniser NR, Sorkin A.

Semin Cell Dev Biol. 2009 Jun;20(4):411-7. doi: 10.1016/j.semcdb.2009.01.004. Epub 2009 Jan 22. Review.

15.

Monoamine transporter as a target molecule for psychostimulants.

Sora I, Li B, Fumushima S, Fukui A, Arime Y, Kasahara Y, Tomita H, Ikeda K.

Int Rev Neurobiol. 2009;85:29-33. doi: 10.1016/S0074-7742(09)85003-4. Review.

PMID:
19607959
16.

Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Zhu J, Reith ME.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):393-409. Review.

18.

Dynamic regulation of the dopamine transporter.

Mortensen OV, Amara SG.

Eur J Pharmacol. 2003 Oct 31;479(1-3):159-70. Review.

PMID:
14612147
19.

Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.

Volz TJ, Fleckenstein AE, Hanson GR.

Addiction. 2007 Apr;102 Suppl 1:44-8. Review.

PMID:
17493052
20.

Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.

Ago Y, Nakamura S, Baba A, Matsuda T.

J Pharmacol Sci. 2008 Jan;106(1):15-21. Epub 2008 Jan 16. Review.

Items per page

Supplemental Content

Write to the Help Desk